SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007846
Filing Date
2022-05-05
Accepted
2022-05-05 16:16:58
Documents
48
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q alec-20220331.htm   iXBRL 10-Q 2036232
2 EX-31.1 alec-ex31_1.htm EX-31.1 28493
3 EX-31.2 alec-ex31_2.htm EX-31.2 28487
4 EX-32.1 alec-ex32_1.htm EX-32.1 10917
5 EX-32.2 alec-ex32_2.htm EX-32.2 10958
  Complete submission text file 0000950170-22-007846.txt   5656247

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT alec-20220331_def.xml EX-101.DEF 125020
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT alec-20220331.xsd EX-101.SCH 30518
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT alec-20220331_lab.xml EX-101.LAB 305082
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT alec-20220331_cal.xml EX-101.CAL 33255
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT alec-20220331_pre.xml EX-101.PRE 219684
42 EXTRACTED XBRL INSTANCE DOCUMENT alec-20220331_htm.xml XML 754827
Mailing Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BLVD., SUITE 600 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 822933343 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38792 | Film No.: 22896513
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences